Wali VB - Search Results

1

Combined gamma-tocotrienol and erlotinib/gefitinib treatment suppresses Stat and Akt signaling in murine mammary tumor cells.

Bachawal SV, Wali VB, Sylvester PW. Bachawal SV, et al. Among authors: wali vb. Anticancer Res. 2010 Feb;30(2):429-37. Anticancer Res. 2010. PMID: 20332450

2

Anti-proliferative effects of gamma-tocotrienol on mammary tumour cells are associated with suppression of cell cycle progression.

Samant GV, Wali VB, Sylvester PW. Samant GV, et al. Among authors: wali vb. Cell Prolif. 2010 Feb;43(1):77-83. doi: 10.1111/j.1365-2184.2009.00657.x. Epub 2009 Nov 17. Cell Prolif. 2010. PMID: 19922488 Free PMC article.

3

Tocotrienol combination therapy results in synergistic anticancer response.

Sylvester PW, Wali VB, Bachawal SV, Shirode AB, Ayoub NM, Akl MR. Sylvester PW, et al. Among authors: wali vb. Front Biosci (Landmark Ed). 2011 Jun 1;16:3183-95. doi: 10.2741/3905. Front Biosci (Landmark Ed). 2011. PMID: 21622228 Review.

4

Synthesis of fluorescent analogues of the anticancer natural products 4-hydroxyphenylmethylene hydantoin and delta-tocotrienol.

Mudit M, Behery FA, Wali VB, Sylvester PW, El Sayed KA. Mudit M, et al. Among authors: wali vb. Nat Prod Commun. 2010 Oct;5(10):1623-6. Nat Prod Commun. 2010. PMID: 21121261

5

Redox-silent tocotrienol esters as breast cancer proliferation and migration inhibitors.

Behery FA, Elnagar AY, Akl MR, Wali VB, Abuasal B, Kaddoumi A, Sylvester PW, El Sayed KA. Behery FA, et al. Among authors: wali vb. Bioorg Med Chem. 2010 Nov 15;18(22):8066-75. doi: 10.1016/j.bmc.2010.09.009. Epub 2010 Sep 19. Bioorg Med Chem. 2010. PMID: 20943398

6

Enhanced antiproliferative and apoptotic response to combined treatment of gamma-tocotrienol with erlotinib or gefitinib in mammary tumor cells.

Bachawal SV, Wali VB, Sylvester PW. Bachawal SV, et al. Among authors: wali vb. BMC Cancer. 2010 Mar 8;10:84. doi: 10.1186/1471-2407-10-84. BMC Cancer. 2010. PMID: 20211018 Free PMC article.

7

Design and preliminary structure-activity relationship of redox-silent semisynthetic tocotrienol analogues as inhibitors for breast cancer proliferation and invasion.

Elnagar AY, Wali VB, Sylvester PW, El Sayed KA. Elnagar AY, et al. Among authors: wali vb. Bioorg Med Chem. 2010 Jan 15;18(2):755-68. doi: 10.1016/j.bmc.2009.11.054. Epub 2009 Nov 27. Bioorg Med Chem. 2010. PMID: 20022507

8

Suppression in mevalonate synthesis mediates antitumor effects of combined statin and gamma-tocotrienol treatment.

Wali VB, Bachawal SV, Sylvester PW. Wali VB, et al. Lipids. 2009 Oct;44(10):925-34. doi: 10.1007/s11745-009-3344-0. Epub 2009 Sep 24. Lipids. 2009. PMID: 19777282

9

Endoplasmic reticulum stress mediates gamma-tocotrienol-induced apoptosis in mammary tumor cells.

Wali VB, Bachawal SV, Sylvester PW. Wali VB, et al. Apoptosis. 2009 Nov;14(11):1366-77. doi: 10.1007/s10495-009-0406-y. Apoptosis. 2009. PMID: 19771520

10

Combined treatment of gamma-tocotrienol with statins induce mammary tumor cell cycle arrest in G1.

Wali VB, Bachawal SV, Sylvester PW. Wali VB, et al. Exp Biol Med (Maywood). 2009 Jun;234(6):639-50. doi: 10.3181/0810-RM-300. Epub 2009 Apr 9. Exp Biol Med (Maywood). 2009. PMID: 19359655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results